| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.39 | 0.08 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.08 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |